# Faeth Therapeutics, Inc.: Form 8-K, filed Mar 30, 2026

- Company: [Faeth Therapeutics, Inc.](/companies/fth.md) (CIK 1829802)
- Form: 8-K
- Filed: 2026-03-30
- Accepted by EDGAR: Mar 30, 2026, 07:35 ET
- Period: 2026-03-30
- Accession: 0001193125-26-130419
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1829802/000119312526130419/d118677d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1829802/000119312526130419/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1829802/000119312526130419/d118677d8k.htm

Filed Mar 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-130419. Last ingested by Listed: Nov 14, 2026, 19:01 ET. No prices; not investment advice.
